![Tim Coughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tim Coughlin
Chairman at
ATYR PHARMA, INC.
Net worth: 3 M $ as of 2026-05-30
Profile
Timothy P.
Coughlin is Chairman at aTyr Pharma, Inc. since 2024.
He is a Non-Executive Director at ADC Therapeutics SA starting in 2025.
He serves as an Independent Director at Travere Therapeutics, Inc. since 2015.
He is a Director at Vir Biotechnology, Inc. beginning in 2026.
Former roles include Independent Director at Fate Therapeutics, Inc. from 2015 to 2025, Director at Peloton Therapeutics, Inc. in 2019, Senior Manager-Health Sciences Practice at Ernst & Young LLP from 1989 to 1999, Chief Financial Officer at Neurocrine Biosciences, Inc., and Vice President-Financial Services at CommonSpirit Health from 1999 to 2002.
Education includes a graduate degree from San Diego State University conferred in 2002 and an undergraduate degree from Temple University (Pennsylvania) conferred in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-11 | 56,250 ( 0.06% ) | 3 M $ | 2026-05-30 | |
ADC THERAPEUTICS LTD 0.06% | 2026-06-02 | 72,400 ( 0.06% ) | 246 160 $ | 2026-05-30 |
ATYR PHARMA, INC. 0.06% | 2026-05-10 | 56,000 ( 0.06% ) | 30 408 $ | 2026-05-30 |
Tim Coughlin active positions
| Companies | Position | Start |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Board Member | 2015-03-30 |
| ATYR PHARMA, INC. | Chairman | 2024-03-13 |
| ADC THERAPEUTICS SA | Director/Board Member | 2025-05-31 |
| VIR BIOTECHNOLOGY, INC. | Director/Board Member | 2026-06-08 |
Former positions of Tim Coughlin
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Board Member | 2025-05-28 |
| PELOTON THERAPEUTICS, INC. | Director/Board Member | 2019-11-30 |
CommonSpirit Health (Illinois)
 CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Director of Finance/CFO | 2001-12-31 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 1998-12-31 |
| NEUROCRINE BIOSCIENCES, INC. | Director of Finance/CFO | - |
Training of Tim Coughlin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
100
+
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Commercial Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
- Stock Market
- Insiders
- Tim Coughlin
